Panoply™ Human KCNN4 Knockdown Stable Cell Line

KCNN4 belongs to the calcium-activated potassium channel subfamily, and growing evidence links it closely to malignant tumors. However, research regarding the role and regulatory mechanisms of KCNN4 in pancreatic ductal adenocarcinoma (PDAC) remains limited. Here, researchers found that KCNN4 expression is aberrantly elevated in PDAC tissues and that this overexpression is induced by the transcription factor AP-1. High KCNN4 expression correlates significantly with adverse clinicopathological features and poor survival outcomes. Functional assays demonstrated that KCNN4 overexpression promotes PDAC cell proliferation, migration, and invasion, whereas KCNN4 knockdown inhibits cell growth and motility. Furthermore, KCNN4 knockdown induces apoptosis and causes cell cycle arrest at the S phase in PDAC cells. Mechanistic studies via RNA sequencing revealed that the MET-mediated AKT signaling pathway plays a pivotal role in KCNN4-promoted PDAC cell proliferation and migration. Collectively, these findings elucidate the function of KCNN4 in PDAC, suggesting its potential as a promising therapeutic target and tumor biomarker.

Given the strong metastatic potential of pancreatic ductal adenocarcinoma (PDAC), researchers evaluated whether KCNN4 influences the migration and invasion capabilities of PDAC cells. Transwell assays demonstrated that KCNN4 knockdown inhibited the migration and invasion of PDAC cells (Figure 1a), whereas KCNN4 overexpression had the opposite effect (Figure 1b). Furthermore, wound-healing assays confirmed that the motility of KCNN4-knockdown cells was reduced (Figure 1c). Previous studies have shown that epithelial-mesenchymal transition (EMT) plays a pivotal role in morphogenesis and the initiation of tumor progression. Consequently, the researchers examined the expression of EMT-related markers (E-cadherin and vimentin) in ASPC1 cells via immunoblotting. The results (Figure 1d) showed that KCNN4 knockdown significantly inhibited the EMT process, while KCNN4 overexpression accelerated it. Immunofluorescence assays further corroborated these findings (Figure 1e). Collectively, these results indicate that KCNN4 promotes EMT and motility in PDAC cells.

Figure 1. KCNN4 promotes the motility of PDAC. (Mo X, et al., 2022)